Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

LIMN US Equity

Liminatus Pharma, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1971387 · FY ends Dec 31
$5.16
-0.47 (-8.35%)
USD · as of 2026-08-21 · marketstack
DateEventWhat happened / filerSource
2026-08-188-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-188-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-08-188-K 3.03Material modification to rights of security holderssec.gov ↗
2026-08-188-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-08-048-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-07-308-K 8.01Other eventssec.gov ↗
2026-07-248-K 8.01Other eventssec.gov ↗
2026-07-248-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-07-2213GSchedule 13G filed — ≥5% beneficial owner (passive) · by Samda Biolab Co., Ltd.sec.gov ↗
2026-07-1413D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Valetudo Therapeutics LLCsec.gov ↗
2026-07-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Ewon Comfortech Co., Ltd.sec.gov ↗
2026-07-068-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-07-068-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-07-068-K 2.01Completion of acquisition or disposition of assetssec.gov ↗
2026-07-068-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.